Osteoarthritis, Hip Clinical Trials
3 recruiting trials for Osteoarthritis, Hip. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Osteoarthritis, Hip clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Turku (1), Imelda Hospital, Bonheiden (1), Istituto Ortopedico Rizzoli (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Total hip arthroplasty (procedure, 1 trial), followed by Blood and bone marrow cell collection, SARC-F questionnaire.
Track Osteoarthritis, Hip trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis
The purpose of this study is to cast light on the highly complex etiology and cellular landscape of hip osteoarthritis by utilising single-cell and spatial omics.
Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)
Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of...
Study of Parameters of Osteosarcopenia in Patients With Hip Fracture
The study aims to assess the adequacy of a set of clinical and laboratory investigations for identifying the osteosarcopenia status in patients undergoing a hip replacement for a...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Osteoarthritis, Hip, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Osteoarthritis, Hip, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Osteoarthritis, Hip, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.